Certain senior US House Democrats objected to the blacklisting of five Chinese-linked biotechnology companies from new federally funded research and contracts, Bloomberg News reported Sunday.
The Biosecure Act would have affected BGI Group, MGI Tech (SHA:688114), Complete Genomics., WuXi AppTec (HKG:2359, SHA:603259) and WuXi Biologics (HKG:2269), according to the report.
Jim McGovern of Massachusetts and Jamie Raskin of Maryland said there should be due process to get on and off any list that excludes companies from research funded by the US, Bloomberg wrote.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。